42 results on '"Salvadori, Nicolas"'
Search Results
2. Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
3. Hepatitis B prevalence and associated factors in adults presenting for infection screening in northern Thailand
4. THU-362 Ravidasvir in combination with sofosbuvir for 12 or 24 weeks achieved high sustained virological response rates in genotype 3 chronic hepatitis C without or with compensated liver cirrhosis
5. Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
6. Real-world evidence of survival benefit of remdesivir: study of 419 propensity score-matched patients hospitalized over the alpha and delta waves of COVID-19 in New Orleans, LA.
7. Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
8. Uptake, acceptability and interpretability of 3‐in‐1 rapid blood self‐testing for HIV, hepatitis B and hepatitis C
9. Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study
10. Appointment reminders to increase uptake of HIV retesting by at-risk individuals: a randomized controlled study in Thailand
11. Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study
12. Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study
13. Tenofovir Versus Placebo to Prevent Perinatal Transmission of Hepatitis B
14. Chronic Kidney Disease in a Large National Human Immunodeficiency Virus Treatment Program
15. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretrovial Therapy
16. Zika Virus Immunoglobulin G Seroprevalence among Young Adults Living with HIV or without HIV in Thailand from 1997 to 2017
17. Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus
18. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015
19. Impact of Zika virus on the human type I interferon osteoimmune response
20. Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial
21. Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study
22. Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
23. Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program
24. Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform
25. Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program
26. Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6 : the STORM-C-1 phase II/III trial
27. Feasibility of using dried blood spots for HIV viral load testing among HIV‐infected individuals in Thailand using QIAGEN QIAsymphony‐artusHIV‐1 platform
28. Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study
29. Feasibility of using dried blood spots for HIV viral load testing among HIV‐infected individuals in Thailand using QIAGEN QIAsymphony‐artus HIV‐1 platform.
30. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B
31. A population pharmacokinetic/pharmacodynamic model predicts favorable hdl cholesterol changes over the first 5 years in children treated with current efavirenz-based regimens
32. Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
33. Potential Missed Opportunities Related to the Systematic Screening for Hepatitis B Surface Antigen in Thailand
34. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
35. A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz‐Based Regimens
36. Efavirenz Concentrations and Probability of HIV Replication in Children
37. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand
38. PK & SAFETY OF ABC/3TC DISPERSIBLE TABLETS & LPV/r GRANULES IN NEONATES: PETITE STUDY.
39. Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
40. Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment.
41. Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study.
42. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.